Prospekta

N/A

Report date: 2022/11/27 19:39:10

Base Information

Drug NameProspekta
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsPost-Acute COVID-19 Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryRussian Federation
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesMateria Medica Holding
China Registration ClassN/A

Develop Information

Active CompaniesMateria Medica Holding
Inactive CompaniesN/A
Active IndicationsPost-Acute COVID-19 Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A